Inventor · disambiguated record
Andreas Bikfalvi
Also filed as: BIKFALVI ANDREAS · BIKFALVI ANDRÉAS
4 granted patents·7 pending applications·22 citations·filing 2001–2022
65Inventor score
Files withBIKFALVI ANDREAS4COMMISSARIAT ENERGIE ATOMIQUE2INST NAT SANTE RECH MED2INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE1UNIV BORDEAUX1
Top patents by PatentIndex Score
11 records- 0185US7199100B2Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activatorCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2001·Granted Apr 3, 2007·22 cites·130 claims
- 0251US2024316005A1Gene signatures for predicting survival time in patients suffering from renal cell carcinomaINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0349USRE44022ECyclic peptides, method for preparing and use as angiogenesis inhibitors or activatorsCOMMISSARIAT ENERGIE ATOMIQUE·Filed 2001·Granted Feb 19, 2013·0 cites·130 claims
- 0448US2011318370A1Cxcl4l1 as a biomarker of pancreatic cancerBIKFALVI ANDREAS·Filed 2009·Application pending·0 cites
- 0545US8481033B2Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)BIKFALVI ANDREAS·Filed 2009·Granted Jul 9, 2013·0 cites·5 claims
- 0639US2015246118A1Lyve-1 antagonists for preventing or treating a pathological condition associated with lymphangiogenesisINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2013·Application pending·0 cites
- 0739US2022137054A1New biomarkers and biotargets in renal cell carcinomaINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 0838US2020002681A1Hollow cellular microfibre and method for producing such a hollow cellular microfibreUNIV BORDEAUX·Filed 2018·Application pending·0 cites
- 0935US2010150872A1Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2BIKFALVI ANDREAS·Filed 2007·Application pending·0 cites
- 1030US2004086999A1Mutated-pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiognesisFiled 2001·Application pending·0 cites
- 1129US8940702B2Mutants PF4 polypeptides exhibiting an increased anti-angiogenic activityBIKFALVI ANDREAS·Filed 2010·Granted Jan 27, 2015·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →